Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge

Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge

Carbapenem-resistant Pseudomonas aeruginosa (CR-PA) is a major healthcare-associated pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are carbapenem-resistant, while globally the percentage varies considerably. A subset of carbapenem-resistant P. aeruginosa isolates harbour...

Full description

Bibliographic Details
Main Authors: Fred C. Tenover, David P. Nicolau, Christian M. Gill
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Emerging Microbes and Infections
Subjects:
Pseudomonas aeruginosa
carbapenems
carbapenemase
susceptibility testing
beta-lactamase
beta-lactamase inhibitor
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2022.2048972

Internet

https://www.tandfonline.com/doi/10.1080/22221751.2022.2048972

Similar Items